Resumen
Definición
History and exam
Key diagnostic factors
- наличие факторов риска
- лихорадка ≥37.5 °C
- кровотечение (десны, желудочно-кишечный тракта, метроррагия)
- петехии
- конъюнктивит
Other diagnostic factors
- недомогание
- головная боль
- артралгия
- миалгия
- боль в брюшной полости
- тошнота/рвота
- диарея
- лимфаденопатия
- неврологические симптомы например, дезориентация, атаксия, судороги)
- боль в горле
- кашель
- прострация/кома
Risk factors
- профессиональный риск
- контакт с соответствующими видами грызунов
- взрослые мужчины
- контакт с инфицированным человеком
- проживание в эндемичном регионе
Diagnostic investigations
1st investigations to order
- полимеразная цепная реакция с обратной транскрипцией (RT-PCR)
- Иммуноферментный анализ (ИФА)
- развернутый анализ крови
Investigations to consider
- исследование на малярию
- бактериологическое исследование крови
- уровень электролитов и функция почек
- функция печени
- коагулограмма
- лактат дегидрогеназа (ЛДГ)
- креатинфосфокиназа
- Рентгенография органов грудной клетки
- исследование газового состава артериальной крови
Treatment algorithm
пациенты с наличием симптомов
Contributors
Authors
Nathalie MacDermott, MBBCh
Wellcome Clinical Research Training Fellow
Imperial College London
London
UK
Disclosures
NMD declares that she has no competing interests.
Thomas G. Ksiazek, DVM, PhD
Professor
University of Texas Medical Branch (UTMB) at Galveston
Galveston
TX
Disclosures
TGK has grants and contracts from NIH but is not involved in drug or vaccine research relating to South American haemorrhagic fevers. He has patents in regard to Ebola, Rift Valley fever, and hantaviruses. TGK is an author of a reference cited in this topic.
Peer reviewers
Stalin Vilcarromero, MD
Research Physician
US Naval Medical Research Unit 6 (NAMRU-6)
Iquitos
Peru
Disclosures
SV declares that he has no competing interests.
Vanessa Raabe, MD, MSc
Adult and Pediatric Infectious Disease Fellow
Emory University
Atlanta
GA
Disclosures
VR declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Patterson M, Grant A, Paessler S. Epidemiology and pathogenesis of Bolivian hemorrhagic fever. Curr Opin Virol. 2014;5:82-90.Full text Abstract
Gómez RM, Jaquenod de Giusti C, Sanchez Vallduvi MM, et al. Junín virus. A XXI century update. Microbes Infect. 2011;13:303-311. Abstract
Enria DA, Briggiler AM, Sánchez Z. Treatment of Argentine hemorrhagic fever. Antiviral Res. 2008;78:132-139. Abstract
Enria DA, Briggiler AM, Feuillade MR. An overview of the epidemiological, ecological and preventive hallmarks of Argentine haemorrhagic fever (Junin virus). Bulletin Institut Pasteur. 1998;96:103-114.
de Manzione N, Salas RA, Paredes H, et al. Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin Infect Dis. 1998;26:308-313.Full text Abstract
Delgado S, Erickson BR, Agudo R, et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 2008;4:e1000047.Full text Abstract
Grant A, Seregin A, Huang C, et al. Junín virus pathogenesis and virus replication. Viruses. 2012;4:2317-2339.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Инфекция малярии
- Лихорадка Денге
- Желтая лихорадка
More DifferentialsGuidelines
- CDC Health Information for International Travel (Yellow Book): viral hemorrhagic fevers
- Management of Hazard Group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence
More GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer